Moreover, FOXD1 knockdown resulted in a significant reduction of NAT10 expression at both mRNA and protein levels in HNE3 and C666-1 NPC cells (Fig. 5E and F). This evidence concerns the gene NAT10 and nasopharyngeal carcinoma.